Distinct Roles of β-Cell Mass and Function During Type 1 Diabetes Onset and Remission
Distinct Roles of β-Cell Mass and Function During Type 1 Diabetes Onset and Remission
复制标题
DOI:
10.2337/db14-1055
复制
发表时间:
2015-06-01
期刊:
影响因子:
7.7
通讯作者:
Speier, Stephan
中科院分区:
文献类型:
--
作者:
Chmelova, Helena;Cohrs, Christian M.;Speier, Stephan
Cure of type 1 diabetes (T1D) by immune intervention at disease onset depends on the restoration of insulin secretion by endogenous beta-cells. However, little is known about the potential of beta-cell mass and function to recover after autoimmune attack ablation. Using a longitudinal in vivo imaging approach, we show how functional status and mass of beta-cells adapt in response to the onset and remission of T1D. We demonstrate that infiltration reduces beta-cell mass prior to onset and, together with emerging hyperglycemia, affects beta-cell function. After immune intervention, persisting hyperglycemia prevents functional recovery but promotes beta-cell mass increase in mouse islets. When blood glucose levels return to normoglycemia beta-cell mass expansion stops, and subsequently glucose tolerance recovers in combination with beta-cell function. Similar to mouse islets, human islets exhibit cell exhaustion and recovery in response to transient hyperglycemia. However, the effect of hyperglycemia on human islet mass increase is minor and transient. Our data demonstrate a major role of functional exhaustion and recovery of beta-cells during T1D onset and remission. Therefore, these findings support early intervention therapy for individuals with T1D.